00000000nam 2200000zi 4500
0019.954011
003CaOODSP
00520250825105607
006m     o  d f      
007cr mn|||||||||
008250812s2024    onca    obs  f000 0 eng d
040 |aCaOODSP|beng|erda|cCaOODSP
0410 |aeng|afre
043 |an-cn---
045 |ay1y2
0861 |aH82-59/2024-PDF
1001 |aGaudette, Étienne, |d1953- |eauthor.
24510|aDo higher prices provide protection against drug shortages? : |bReal-world evidence lessons from Canada / Étienne Gaudette, Shirin Rizzardo, Kevin R. Pothier, and Mina Tadrous = Des prix plus élevés offrent-ils une protection contre les pénuries de médicaments? : Leçons concrètes tirées du Canada / Étienne Gaudette,Shirin Rizzardo, Kevin R. Pothier et Mina Tadrous.
24611|aDes prix plus élevés offrent-ils une protection contre les pénuries de médicaments? : |bLeçons concrètes tirées du Canada
264 1|a[Ottawa] : |bPatented Medicine Prices Review Board = Conseil d'examen du prix des médicaments brevetés, |c[2024]
300 |a1 online resource (1 page) : |bcolour illustrations
336 |atext|btxt|2rdacontent
337 |acomputer|bc|2rdamedia
338 |aonline resource|bcr|2rdacarrier
500 |a"NPDUIS, National Prescription Drug Utilization Information System."
504 |aIncludes bibliographical references.
546 |aText in English and French.
650 0|aDrugs|xPrices|zCanada|vStatistics.
650 0|aDrug accessibility|zCanada|vStatistics.
655 7|aStatistics|2lcgft
655 7|aPosters|2lcgft
7101 |aCanada. |bPatented Medicine Prices Review Board, |eissuing body.
788 |tDo higher prices provide protection against drug shortages? : |efre|w(CaOODSP)9.954010
85640|qPDF|s153 KB|uhttps://publications.gc.ca/collections/collection_2025/cepmb-pmprb/H82-59-2024.pdf
8564 |qHTML|sN/A|uhttps://www.canada.ca/en/patented-medicine-prices-review/services/npduis/analytical-studies/posters/higher-prices-drug-shortages.html